MARKET WIRE NEWS

Expected US Company Earnings on Tuesday, March 17th, 2026

Source: US Earnings Reports


Fold Holdings Inc. (FLD) is expected to report $-0.14 for Q4 2025

Modiv Industrial Inc. Class C (MDV) is expected to report $0.37 for Q4 2025

Qfin Holdings Inc. (QFIN) is expected to report $1.13 for Q4 2025

Neo Performance Materials Inc (NOPMF) is expected to report $0.14 for Q4 2025

Neuronetics Inc. (STIM) is expected to report $-0.12 for Q4 2025

ClearPoint Neuro, Inc. (CLPT) is expected to report $-0.22 for Q4 2025

Cibus Inc. (CBUS) is expected to report $-0.43 for Q4 2025

Titan America SA (TTAM) is expected to report $0.25 for Q4 2025

Atour Lifestyle Holdings Limited (ATAT) is expected to report $0.43 for Q4 2025

Bob's Discount Furniture Inc. (BOBS) is expected to report $0.3 for Q4 2025

MiNK Therapeutics Inc. (INKT) is expected to report $-0.68 for Q4 2025

Andersen Group Inc. Class A (ANDG) is expected to report $-0.28 for Q4 2025

Oklo Inc. Class A (OKLO) is expected to report $-0.18 for Q4 2025

Kestra Medical Technologies Ltd. (KMTS) is expected to report $-0.6 for Q3 2026

Instil Bio Inc. (TIL) is expected to report $-2.31 for Q4 2025

Academy Sports and Outdoors Inc. (ASO) is expected to report $1.99 for Q4 2026

Elbit Systems Ltd. (ESLT) is expected to report $3.23 for Q4 2025

HealthEquity Inc. (HQY) is expected to report $0.7 for Q4 2026

Alimentation-Couche Tard Inc. - Class A (Multiple Voting) (ANCTF) is expected to report $0.77 for Q3 2026

Telomir Pharmaceuticals Inc. (TELO) is expected to report $-0.07 for Q4 2025

Vireo Growth Inc Com (VREOF) is expected to report $0.01 for Q4 2025

GDS Holdings Limited (GDS) is expected to report $-0.01 for Q4 2025

Longeveron Inc. (LGVN) is expected to report $-0.41 for Q4 2025

Trevi Therapeutics Inc. (TRVI) is expected to report $-0.1 for Q4 2025

Telesat Corporation (TSAT) is expected to report $-1.05 for Q4 2025

Ovid Therapeutics Inc. (OVID) is expected to report $-0.1 for Q4 2025

Corporacion America Airports SA (CAAP) is expected to report $0.37 for Q4 2025

Bioceres Crop Solutions Corp. (BIOX) is expected to report $0.07 for Q2 2026

IceCure Medical Ltd. (ICCM) is expected to report $-0.04 for Q4 2025

Pyxis Oncology Inc. (PYXS) is expected to report $-0.35 for Q4 2025

Stoke Therapeutics Inc. (STOK) is expected to report $-0.75 for Q4 2025

Bicycle Therapeutics plc (BCYC) is expected to report $-1 for Q4 2025

Tencent Music Entertainment Group American Depositary Shares each representing two Class A (TME) is expected to report $0.21 for Q4 2025

IHS Holding Limited (IHS) is expected to report $0.17 for Q4 2025

HUYA Inc. American depositary shares each representing one Class A (HUYA) is expected to report $0.02 for Q4 2025

Eve Holding Inc. (EVEX) is expected to report $-0.14 for Q4 2025

Achieve Life Sciences Inc. (ACHV) is expected to report $-0.27 for Q4 2025

NextNav Inc. (NN) is expected to report $-0.13 for Q4 2025

DocuSign Inc. (DOCU) is expected to report $0.34 for Q4 2026

Abeona Therapeutics Inc. (ABEO) is expected to report $-0.35 for Q4 2025

Silexion Therapeutics Corp (SLXN) is expected to report $-1.17 for Q4 2025

Tvardi Therapeutics Inc. (TVRD) is expected to report $-0.55 for Q4 2025

Alvopetro Energy (ALVOF) is expected to report $0.14 for Q4 2025

Xilio Therapeutics Inc. (XLO) is expected to report $-0.12 for Q4 2025

PSQ Holdings Inc. Class A (PSQH) is expected to report $-0.19 for Q4 2025

Cyclerion Therapeutics Inc. (CYCN) is expected to report $-0.38 for Q4 2025

Werewolf Therapeutics Inc. (HOWL) is expected to report $-0.34 for Q4 2025

Ashtead Group plc ADR (ASHTY) is expected to report $3.28 for Q3 2026

lululemon athletica inc. (LULU) is expected to report $4.77 for Q4 2026

DiDi Global Inc. American Depositary Shares (each four representing one Class A) (DIDIY) is expected to report $0.01 for Q4 2025


Atour Lifestyle Holdings Limited

NASDAQ: ATAT

ATAT Trading

6.92% G/L:

$37.305 Last:

1,577,499 Volume:

$35.335 Open:

mwn-alerts Ad 300

ATAT Latest News

November 25, 2025 01:15:04 pm
Buy Recommendation Issued On ATAT By Citigroup

ATAT Stock Data

$5,505,328,288
74,482,228
N/A
60
N/A
Hotels, Lodging & Leisure
Consumer Discretionary
CN
Shanghai

Subscribe to Our Newsletter

Link Market Wire News to Your X Account

Download The Market Wire News App